Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 159,839 | 173,594 | 0 | N/A | 0 |
| TOTAL | $162,864 | $175,926 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 8,149 | 2,912 | N/A | N/A | N/A |
| Other Non-Current Assets | 1,780 | 1,780 | 0 | 0 | 0 |
| TOTAL | $9,929 | $4,692 | $N/A | $N/A | $N/A |
| Total Assets | $172,793 | $180,618 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,897 | 1,497 | 0 | 0 | 0 |
| Accrued Expenses | 7,032 | 6,108 | 0 | N/A | 0 |
| TOTAL | $11,929 | $7,605 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,080 | 796 | 0 | 0 | 0 |
| TOTAL | $1,080 | $796 | $N/A | $N/A | $N/A |
| Total Liabilities | $13,009 | $8,401 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,072 | 2,059 | N/A | N/A | N/A |
| Common Shares | 33 | 33 | 0 | N/A | 0 |
| Retained earnings | -86,047 | -70,032 | 0 | N/A | 0 |
| TOTAL | $159,784 | $172,217 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $172,793 | $180,618 | $0 | $0 | $0 |